Rosmarinic acid mitigates learning and memory disturbances in amyloid β(25–35)-induced model of Alzheimer’s disease in rat

Authors

Abstract:

Abstract Background and Objective: Alzheimer’s disease (AD) is a weakening neurodegenerative disorder typified by increased b-amyloid (Ab) deposition and neuronal dysfunction causing to impaired learning and memory. Among proposed risk factors, induced oxidative stress is a main cause for incidence of the disease. The aim of this study was to determine the effects of the rosmarinic acid on learning and memory impairments with emphasis on its antioxidant properties. Materials and Methods: In the present study, the effect of the intraperitoneally administration of rosmarinic acid (10 and 20 mg/kg) on learning and memory impairments was assessed in intrahippocampal Ab(25–35)-injected rats. Results: The results showed that the intrahippocampal Ab(25–35)-injected rats exhibit lower spontaneous alternation score inY-maze tasks (pConclusion: This study indicates that rosmarinic acid pretreatment ameliorates Ab-induced impairment of learning and memory in rats via attenuation of oxidative stress burden.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

rosmarinic acid mitigates learning and memory disturbances in amyloid β(25–35)-induced model of alzheimer’s disease in rat

abstract background and objective: alzheimer’s disease (ad) is a weakening neurodegenerative disorder typified by increased b-amyloid (ab) deposition and neuronal dysfunction causing to impaired learning and memory. among proposed risk factors, induced oxidative stress is a main cause for incidence of the disease. the aim of this study was to determine the effects of the rosmarinic acid on lear...

full text

Varenicline Ameliorates Learning and Memory Deficits in Amyloid β(25–35) Rat Model of Alzheimer’s Disease

Introduction: Alzheimer’s disease (AD) is a enfeeble neurodegenerative disorder characterized by increased β-amyloid (Aβ) deposition and neuronal dysfunction leading to impaired learning and recall. Among proposed risk factors, impaired cholinergic transmission is a main cause for incidence of disease. Methods: In the present study, effects of the intracerebroventricularly administration of an ...

full text

Isorhamnetin mitigates learning and memory disturbances in streptozotocin-induced diabetic rats

Background and Objective: Diabetes as a metabolic disorder can cause memory and learning impairment. In recent years, the effect of plant extracts on the treatment of diabetes mellitus has been raised. The purpose of this study was to determine the effect of isorhmnetin administration on learning and memory disability in an experimental model of streptozotocin-induced diabetes mellitus in rats....

full text

varenicline ameliorates learning and memory deficits in amyloid β(25–35) rat model of alzheimer’s disease

introduction: alzheimer’s disease (ad) is a enfeeble neurodegenerative disorder characterized by increased β-amyloid (aβ) deposition and neuronal dysfunction leading to impaired learning and recall. among proposed risk factors, impaired cholinergic transmission is a main cause for incidence of disease. methods: in the present study, effects of the intracerebroventricularly administration of an ...

full text

Ellagic acid improves hyperalgesia and cognitive deficiency in 6-hydroxidopamine induced rat model of Parkinson’s disease

Objective(s):Parkinson's disease (PD) is known for motor impairments. But often, there are non-motor symptoms such as cognitive deficiency and pain misperception, owing to possible role of nigrostriatal pathway. Antioxidants have protective effect on free radical-induced neuronal damage in PD. To further address, we examined the effects of ellagic acid (EA) in a rat model of PD induced by 6-hyd...

full text

Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer’s disease

Objective(s): Increasing evidence suggests that Alzheimer’s disease (AD) is associated with diabetes. Rosiglitazone, a peroxisome proliferator-activated receptor γ (PPAR-γ) agonist and anti-diabetic agent, may improve symptoms of AD. However, the underlying therapeutic potential of it has not been fully elucidated. Materials and Methods: Rats were divided into four groups: control group, sham o...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 2  issue 1

pages  7- 14

publication date 2013-02-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023